Cover Image
市場調查報告書

體外受精 (IVF)的全球市場的預測 ∼2021年:培養器、冷凍系統、精子分離系統、細胞凍結保存培養基、胚培養液

In Vitro Fertilization Market by Product (Incubators, Cryosystem, Sperm Seperation System, Cryopreservation Media, Embryo Culture Media), Technology (Pre-Implantation Genetic Diagnosis, Intra-Cytoplasmic Sperm Injection) & End Users - Forecast to 2021

出版商 MarketsandMarkets 商品編碼 364905
出版日期 內容資訊 英文 161 Pages
訂單完成後即時交付
價格
Back to Top
體外受精 (IVF)的全球市場的預測 ∼2021年:培養器、冷凍系統、精子分離系統、細胞凍結保存培養基、胚培養液 In Vitro Fertilization Market by Product (Incubators, Cryosystem, Sperm Seperation System, Cryopreservation Media, Embryo Culture Media), Technology (Pre-Implantation Genetic Diagnosis, Intra-Cytoplasmic Sperm Injection) & End Users - Forecast to 2021
出版日期: 2016年07月27日 內容資訊: 英文 161 Pages
簡介

全球體外受精 (IVF)的市場預計在預測期間內,以10.1%的年複合成長率發展,從2016年的4億6830萬美元,成長到2021年的7億5670萬美元的規模。出生率低和首次懷孕孕婦的高齡化,男性不孕症的增加,醫療費的增加,酒精、香煙消費的擴大,政府倡議的實施,先進的新產品投入等要素促進該市場的成長。

本報告提供全球體外受精 (IVF)的市場調查,市場定義和概要,影響市場成長因素及市場機會分析,產品、技術、終端用戶、地區/各主要國家趨勢與市場規模的變化與預測,競爭環境與市場佔有率,主要經營者簡介等彙整資料。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 全球市場概要
  • 市場分析:各地區、技術
  • 各終端用戶的市場佔有率實際成果、預測

第5章 體外受精 (IVF)的全球市場:概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 推進因素
    • 阻礙因素
    • 市場機會
    • 課題

第6章 體外受精 (IVF)的全球市場:各產品

  • 簡介
  • 試劑
    • 胚培養液
    • 細胞凍結保存培養基
    • 精子處理液
    • 胚珠處理液
  • 設備
    • 成像系統
    • 精子分離系統
    • 機櫃(工作站)
    • 胚珠吸引幫浦
    • 培養器
    • 微型機械手系統
    • 氣體分析儀
    • 雷射系統
    • 冷凍系統
    • 防振台
    • 配件

第7章 體外受精 (IVF)的全球市場:各技術

  • 簡介
  • 卵細胞質內單一精蟲顯微注射術法 (ICSI)
  • 胚胎著床前遺傳基因診斷 (PGD)
  • 凍結胚移植 (FET/FER)
  • 其他

第8章 體外受精 (IVF)的全球市場:各終端用戶

  • 簡介
  • 不孕治療、外科中心
  • 醫院、研究實驗室
  • 精子銀行

第9章 體外受精 (IVF)的全球市場:地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 主要5個國家
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他
  • 其他

第10章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭情形、趨勢
  • 新產品的投入
  • 收購
  • 協定、聯盟、合作、聯盟
  • 產品的認證
  • 擴張
  • 其他

第11章 企業簡介

  • 簡介
  • COOPERSURGICAL, INC.
  • VITROLIFE AB
  • COOK MEDICAL, INC.
  • IRVINE SCIENTIFIC
  • THERMO FISHER SCIENTIFIC, INC.
  • EMD SERONO, INC.
  • GENEA LIMITED
  • ESCO MICRO PTE. LIMITED
  • IVFTECH APS
  • THE BAKER COMPANY, INC.
    • 概要
    • 財務趨勢
    • 產品與服務
    • 策略
    • 發展趨勢等

第12章 附錄

目錄
Product Code: MD 4467

The in vitro fertilization market is expected to reach USD 756.7 million by 2021 from USD 468.3 million in 2016, at a CAGR of 10.1%. Factors such as declining fertility rates, growth in the media age of first-time motherhood, growing cases of male infertility, growth in healthcare expenditure, rise in consumption of alcohol and cigarettes, implementation of government initiatives and introduction of new and advanced products are driving the in vitro fertilization market. However, high cost coupled with low success rate, and restrictive regulation and ethical concerns are expected to restrain the growth of this market to a certain extent.

The intra-cytoplasmic sperm injection segment accounted for the largest share of the global in vitro fertilization market, by technology, in 2016. Growing incidence of male infertility is contributing to the large share of this segment. The embryo culture media accounted for the largest share of the global in vitro fertilization market, by reagents, in 2016 and is expected to grow at the highest CAGR during the forecast period. Imaging systems segment accounted for the largest share of the global in vitro fertilization market, by equipment, in 2016. However, sperm separation systems are expected to grow at the highest CAGR during the forecast period. The fertility and surgical centers segment accounted for the largest share of the global in vitro fertilization market, by end user, in 2016.

Asia-Pacific accounted for the largest share of the in vitro fertilization market in 2016, followed by Europe and North America. The large share of the Asia-Pacific in vitro fertilization market can primarily be attributed to the high maternal age in Japan, abolishment of China's one child policy, rising fertility tourism in India and Thailand, growing surrogacy and high prevalence of PCOS in India and growing number of ART procedures in Australia and New Zealand. In addition, the Asia-Pacific region is projected to grow at the highest CAGR during the forecast period.

Major players in the market are focusing on various strategies such as agreements, alliances, collaborations, and partnerships; new product launches; acquisitions; product approvals; expansions; and other strategies (product enhancement and spin-off), to establish a strong foothold in the global in vitro fertilization market.

CooperSurgical, Inc. (U.S.), Vitrolife AB (Sweden), Cook Medical, Inc. (U.S.), Irvine Scientific (U.S.), Thermo Fisher Scientific, Inc. (U.S.), ESCO Micro Pte. Limited (Singapore), Genea Limited (Australia), The Baker Company (U.S.), IVFtech ApS (Denmark) and EMD Serono, Inc. (U.S.) are some of the key players in the global in vitro fertilization market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the solutions offered by the top players in the in vitro fertilization market. The report analyzes the in vitro fertilization market, by technology, product, end user, and region.
  • Product Development/Innovation: Detailed insights on research and development activities and new product launches in the in vitro fertilization market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for in vitro fertilization across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the in vitro fertilization market
  • Competitive Assessment: In-depth assessment of strategies, products, and distribution networks of the leading players in the in vitro fertilization market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key data from primary sources
      • 2.2.2.2. Key Insights from primary sources
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
    • 2.3.1. RESEARCH DESIGN
  • 2.4. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. CURRENT SCENARIO
  • 3.2. FUTURE OUTLOOK
  • 3.3. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL IN VITRO FERTILIZATION: MARKET OVERVIEW
  • 4.2. GEOGRAPHICAL ANALYSIS: IN VITRO FERTILIZATION MARKET, BY TECHNOLOGY
  • 4.3. IN VITRO FERTILIZATION MARKET SHARE, BY END USER (2016 VS. 2021)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Growth in median age of first-time motherhood
      • 5.3.1.2. Declining fertility rates
      • 5.3.1.3. Growing cases of male infertility
      • 5.3.1.4. Growing consumption of alcohol and cigarettes
      • 5.3.1.5. Implementation of government initiatives to promote IVF treatments
      • 5.3.1.6. Introduction of new and advanced products
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. High cost and low success rate of IVF treatments
      • 5.3.2.2. Restrictive regulations and ethical concerns
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Fertility tourism
    • 5.3.4. CHALLENGE
      • 5.3.4.1. Reduction in efficacy of infertility treatments with advancing age

6. IN VITRO FERTILIZATION MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. REAGENTS
    • 6.2.1. EMBRYO CULTURE MEDIA
    • 6.2.2. CRYOPRESERVATION MEDIA
    • 6.2.3. SPERM PROCESSING MEDIA
    • 6.2.4. OVUM PROCESSING MEDIA
  • 6.3. EQUIPMENT
    • 6.3.1. IMAGING SYSTEMS
    • 6.3.2. SPERM SEPARATION SYSTEMS
    • 6.3.3. CABINETS (WORKSTATIONS)
    • 6.3.4. OVUM ASPIRATION PUMPS
    • 6.3.5. INCUBATORS
    • 6.3.6. MICROMANIPULATOR SYSTEMS
    • 6.3.7. GAS ANALYZERS
    • 6.3.8. LASER SYSTEMS
    • 6.3.9. CRYOSYSTEMS
    • 6.3.10. ANTI-VIBRATION TABLES
    • 6.3.11. ACCESSORIES

7. IN VITRO FERTILIZATION MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. INTRA-CYTOPLASMIC SPERM INJECTION (ICSI)
  • 7.3. PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD)
  • 7.4. FROZEN EMBRYO TRANSFER/REPLACEMENT (FET/FER)
  • 7.5. OTHERS

8. IN VITRO FERTILIZATION MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. FERTILITY AND SURGICAL CENTERS
  • 8.3. HOSPITALS AND RESEARCH LABORATORIES
  • 8.4. CRYOBANKS

9. IN VITRO FERTILIZATION MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
      • 9.2.1.1. Rising postponement of childbirth
      • 9.2.1.2. Declining fertility rates
      • 9.2.1.3. Growing NGO support for IVF
    • 9.2.2. CANADA
      • 9.2.2.1. Rising maternal age
  • 9.3. EUROPE
    • 9.3.1. EUROPE-5
      • 9.3.1.1. Declining birthrate in Germany
      • 9.3.1.2. Government initiatives in Italy
      • 9.3.1.3. Increasing obesity and PCOS rates in the U.K.
      • 9.3.1.4. Rise of IVF tourism in Spain
      • 9.3.1.5. Rising age of first-time pregnancy and rising obesity rate in France
    • 9.3.2. REST OF EUROPE (ROE)
      • 9.3.2.1. RoE: Regulatory laws regarding IVF
  • 9.4. ASIA-PACIFIC (APAC)
    • 9.4.1. JAPAN
      • 9.4.1.1. High maternal age in Japan
      • 9.4.1.2. Introduction of age cap of 42 for subsidized fertility treatment restricts market growth
    • 9.4.2. CHINA
      • 9.4.2.1. Abolishment of China's one-child policy
    • 9.4.3. INDIA
      • 9.4.3.1. High prevalence of PCOS in India
      • 9.4.3.2. Growing surrogacy in India
      • 9.4.3.3. Rising fertility tourism in India
    • 9.4.4. REST OF ASIA-PACIFIC
      • 9.4.4.1. Fertility tourism driving the IVF market in Thailand
      • 9.4.4.2. Growing number of ART procedures in Australia and New Zealand
  • 9.5. REST OF THE WORLD (ROW)
    • 9.5.1. INCREASING INCIDENCE OF RISK FACTORS CAUSING INFERTILITY

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
    • 10.2.1. INTRODUCTION
    • 10.2.2. COOPERSURGICAL, INC. (A SUBSIDIARY OF COOPER COMPANIES, INC.)
    • 10.2.3. VITROLIFE AB
  • 10.3. COMPETITIVE SITUATION AND TRENDS
  • 10.4. NEW PRODUCT LAUNCHES
  • 10.5. ACQUISITIONS
  • 10.6. AGREEMENTS, COLLABORATIONS, ALLIANCES, AND PARTNERSHIPS
  • 10.7. PRODUCT APPROVALS
  • 10.8. EXPANSIONS
  • 10.9. OTHER STRATEGIES

11. COMPANY PROFILES (Overview, Financial*, Products & Services, Strategy, and Developments)

  • 11.1. INTRODUCTION
  • 11.2. COOPERSURGICAL, INC. (A SUBSIDIARY OF THE COOPER COMPANIES, INC.)
  • 11.3. VITROLIFE AB
  • 11.4. COOK MEDICAL, INC.
  • 11.5. IRVINE SCIENTIFIC
  • 11.6. THERMO FISHER SCIENTIFIC, INC.
  • 11.7. EMD SERONO, INC. (SUBSIDIARY OF MERCK KGAA)
  • 11.8. GENEA LIMITED
  • 11.9. ESCO MICRO PTE. LIMITED
  • 11.10. IVFTECH APS
  • 11.11. THE BAKER COMPANY, INC.

*Details might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. COMPANY DEVELOPMENTS (2013-2016)
    • 12.2.1. VITROLIFE AB
    • 12.2.2. IRVINE SCIENTIFIC
    • 12.2.3. THERMO FISHER SCIENTIFIC, INC.
    • 12.2.4. GENEA LIMITED
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 2: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 3: EMBRYO CULTURE MEDIA MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 4: CRYOPRESERVATION MEDIA MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 5: SPERM PROCESSING MEDIA MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 6: OVUM PROCESSING MEDIA MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: IN VITRO FERTILIZATION INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 8: IMAGING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: SPERM SEPARATION SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: CABINETS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: OVUM ASPIRATION PUMPS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: INCUBATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: MICROMANIPULATOR SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: GAS ANALYZERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: LASER SYSTEM MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: CRYOSYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: ANTI-VIBRATION TABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: ACCESSORIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 20: INTRA-CYTOPLASMIC SPERM INJECTION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: PRE-IMPLANTATION GENETIC DIAGNOSIS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: FROZEN EMBRYO TRANSFER MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: OTHER IN VITRO FERTILIZATION TECHNOLOGIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: GLOBAL IN VITRO FERTILIZATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 25: FERTILITY AND SURGICAL CENTERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: HOSPITALS AND RESEARCH LABORATORIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: CRYOBANKS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: IN VITRO FERTILIZATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: NORTH AMERICA: IN VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 30: NORTH AMERICA: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 31: NORTH AMERICA: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 32: NORTH AMERICA: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 33: NORTH AMERICA: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 34: NORTH AMERICA: IN VITRO FERTILIZATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 35: NOTABLE ORGANIZATIONS PROVIDING SUPPORT FOR IVF TREATMENT, U.S.
  • TABLE 36: U.S.: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 37: U.S.: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 38: U.S.: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 39: U.S.: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 40: U.S.: IN VITRO FERTILIZATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 41: CANADA: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 42: CANADA: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 43: CANADA: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 44: CANADA: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 45: CANADA: IN VITRO FERTILIZATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 46: EUROPE: IN VITRO FERTILIZATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 47: EUROPE: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 48: EUROPE: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 49: EUROPE: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 50: EUROPE: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 51: EUROPE: IN VITRO FERTILIZATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 52: AVERAGE COST OF IVF TREATMENT IN SPAIN (2016)
  • TABLE 53: EUROPE-5: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 54: EUROPE-5: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 55: EUROPE-5: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 56: EUROPE-5: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 57: EUROPE-5: IN VITRO FERTILIZATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 58: ROE: REGULATIONS FOR IVF
  • TABLE 59: ROE: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 60: ROE: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 61: ROE: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 62: ROE: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 63: ROE: IN VITRO FERTILIZATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 64: ASIA-PACIFIC: IN VITRO FERTILIZATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 65: ASIA-PACIFIC: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 66: ASIA-PACIFIC: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 67: ASIA-PACIFIC: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 68: ASIA-PACIFIC: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 69: ASIA-PACIFIC: IN VITRO FERTILIZATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 70: JAPAN: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 71: JAPAN: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 72: JAPAN: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 73: JAPAN: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 74: JAPAN: IN VITRO FERTILIZATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 75: CHINA: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 76: CHINA: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 77: CHINA: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 78: CHINA: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 79: CHINA: IN VITRO FERTILIZATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 80: INDIA: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 81: INDIA: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 82: INDIA: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 83: INDIA: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 84: INDIA: IN VITRO FERTILIZATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 85: ROAPAC: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 86: ROAPAC: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 87: ROAPAC: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 88: ROAPAC: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 89: ROAPAC: IN VITRO FERTILIZATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 90: ROW: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 91: ROW: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 92: ROW: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 93: ROW: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 94: ROW: IN VITRO FERTILIZATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 95: RECENT DEVELOPMENTS, 2013-2016
  • TABLE 96: RECENT DEVELOPMENTS, 2013-2016
  • TABLE 97: RECENT DEVELOPMENTS, 2013-2016
  • TABLE 98: RECENT DEVELOPMENTS, 2013-2016
  • TABLE 99: RECENT DEVELOPMENTS, 2013-2016
  • TABLE 100: RECENT DEVELOPMENTS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL IN VITRO FERTILIZATION MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: RESEARCH DESIGN
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: REAGENTS SEGMENT TO DOMINATE THE GLOBAL IN VITRO FERTILIZATION MARKET IN 2016
  • FIGURE 8: ICSI TECHNOLOGY SEGMENT WILL CONTINUE TO DOMINATE THE IVF MARKET IN 2021
  • FIGURE 9: FERTILITY AND SURGICAL CENTERS SEGMENT TO DOMINATE THE GLOBAL IN VITRO FERTILIZATION MARKET IN 2016
  • FIGURE 10: ASIA-PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD
  • FIGURE 11: GLOBAL IN VITRO FERTILIZATION MARKET PROJECTED TO GROW AT A DOUBLE-DIGIT CAGR FROM 2016 TO 2021
  • FIGURE 12: ICSI TECHNOLOGY TO DOMINATE THE IVF MARKET IN 2016
  • FIGURE 13: ASIA-PACIFIC REGION TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD
  • FIGURE 14: FERTILITY AND SURGICAL CENTERS TO COMMAND THE LARGEST SHARE IN 2016
  • FIGURE 15: IN VITRO FERTILIZATION MARKET SEGMENTATION
  • FIGURE 16: IN VITRO FERTILIZATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 17: REDUCTION IN THE MEAN AGE OF CHILDBEARING, BY REGION
  • FIGURE 18: REDUCTION IN NUMBER OF BIRTHS PER WOMEN (2003-2050)
  • FIGURE 19: REAGENTS TO ACCOUNT FOR THE LARGEST SHARE OF THE IN VITRO FERTILIZATION MARKET IN 2016
  • FIGURE 20: EMBRYO CULTURE MEDIA TO ACCOUNT FOR THE LARGEST SHARE OF IN VITRO FERTILIZATION REAGENTS MARKET IN 2016
  • FIGURE 21: IMAGING SYSTEMS TO ACCOUNT FOR THE LARGEST SHARE OF THE IN VITRO FERTILIZATION EQUIPMENT MARKET IN 2016
  • FIGURE 22: INTRA-CYTOPLASMIC SPERM INJECTION TECHNOLOGY TO ACCOUNT FOR THE LARGEST SHARE OF IN VITRO FERTILIZATION MARKET IN 2016
  • FIGURE 23: FERTILITY AND SURGICAL CENTERS TO ACCOUNT FOR THE LARGEST SHARE OF THE IN VITRO FERTILIZATION MARKET IN 2016
  • FIGURE 24: ASIA-PACIFIC TO COMMAND THE LARGEST SHARE OF THE IN VITRO FERTILIZATION MARKET IN 2016
  • FIGURE 25: NORTH AMERICAN IN VITRO FERTILIZATION MARKET SNAPSHOT
  • FIGURE 26: EUROPE IN VITRO FERTILIZATION MARKET SNAPSHOT
  • FIGURE 27: ASIA-PACIFIC IN VITRO FERTILIZATION MARKET SNAPSHOT, 2016
  • FIGURE 28: ROW IN VITRO FERTILIZATION MARKET SNAPSHOT, 2016
  • FIGURE 29: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 30: KEY DEVELOPMENTS ADOPTED BY THE LEADING PLAYERS IN THE MARKET FROM 2013 TO 2016
  • FIGURE 31: NEW PRODUCT LAUNCHES WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS
  • FIGURE 32: NEW PRODUCT LAUNCHES, BY COMPANY (2013-2016)
  • FIGURE 33: ACQUISITIONS, BY COMPANY (2013-2016)
  • FIGURE 34: AGREEMENTS, COLLABORATIONS, ALLIANCES, AND PARTNERSHIPS, BY COMPANY (2013-2016)
  • FIGURE 35: PRODUCT APPROVALS, BY COMPANY (2013-2016)
  • FIGURE 36: EXPANSIONS, BY COMPANY (2013-2016)
  • FIGURE 37: OTHER STRATEGIES, BY COMPANY (2013-2016)
  • FIGURE 38: GEOGRAPHICAL REVENUE MIX OF THE LEADING PLAYERS IN THE MARKET
  • FIGURE 39: COMPANY SNAPSHOT: COOPERSURGICAL. INC.
  • FIGURE 40: COMPANY SNAPSHOT: VITROLIFE AB
  • FIGURE 41: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC.
Back to Top